Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cass

Showing results (111-120 of 304) with videos related to

Pageof 31
Sort By:
Molecular Cancer Therapeutics|December 19, 2014
Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy?Vijaya L Damaraju, Michelle Kuzma, Delores Mowles, et al.
The Journal of Biological Chemistry|July 20, 2016
Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors: IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORSVijaya L Damaraju, Dwayne Weber, Michelle Kuzma, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|November 13, 2001
[Cloning and expression of Aspergillus niger glucose oxidase gene in methylotrophic yeast]Y F Zhou, X E Zhang, H Liu, et al.
Cancer Treatment Reports|February 1, 1982
Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycinC E Cass, M Selner, T H Tan, et al.
The Biochemical Journal|September 27, 2018
Role of cysteine 416 in <i>N</i>-ethylmaleimide sensitivity of human equilibrative nucleoside transporter 1 (hENT1)Sylvia Y M Yao, Amy M L Ng, Carol E Cass, et al.
Biochemical Pharmacology|July 10, 2018
Multitargeted kinase inhibitors imatinib, sorafenib and sunitinib perturb energy metabolism and cause cytotoxicity to cultured C2C12 skeletal muscle derived myotubesVijaya L Damaraju, Michelle Kuzma, Carol E Cass, et al.
Neuropharmacology|November 19, 1997
Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cellsH Boleti, I R Coe, S A Baldwin, et al.
The Biochemical Journal|July 15, 1996
Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cellsX Fang, F E Parkinson, D A Mowles, et al.
European Journal of Human Genetics : EJHG|January 20, 2012
A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibilityYadav Sapkota, Paula Robson, Raymond Lai, et al.
Genomics|October 15, 1997
Assignment of the human equilibrative nucleoside transporter (hENT1) to 6p21.1-p21.2I R Coe, M Griffiths, J D Young, et al.
Pageof 31

Showing results (111-120 of 304) with videos related to

Sort By:
Pageof 31
Molecular Cancer Therapeutics|December 19, 2014
Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy?Vijaya L Damaraju, Michelle Kuzma, Delores Mowles, et al.
The Journal of Biological Chemistry|July 20, 2016
Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors: IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORSVijaya L Damaraju, Dwayne Weber, Michelle Kuzma, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|November 13, 2001
[Cloning and expression of Aspergillus niger glucose oxidase gene in methylotrophic yeast]Y F Zhou, X E Zhang, H Liu, et al.
Cancer Treatment Reports|February 1, 1982
Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycinC E Cass, M Selner, T H Tan, et al.
The Biochemical Journal|September 27, 2018
Role of cysteine 416 in <i>N</i>-ethylmaleimide sensitivity of human equilibrative nucleoside transporter 1 (hENT1)Sylvia Y M Yao, Amy M L Ng, Carol E Cass, et al.
Biochemical Pharmacology|July 10, 2018
Multitargeted kinase inhibitors imatinib, sorafenib and sunitinib perturb energy metabolism and cause cytotoxicity to cultured C2C12 skeletal muscle derived myotubesVijaya L Damaraju, Michelle Kuzma, Carol E Cass, et al.
Neuropharmacology|November 19, 1997
Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cellsH Boleti, I R Coe, S A Baldwin, et al.
The Biochemical Journal|July 15, 1996
Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cellsX Fang, F E Parkinson, D A Mowles, et al.
European Journal of Human Genetics : EJHG|January 20, 2012
A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibilityYadav Sapkota, Paula Robson, Raymond Lai, et al.
Genomics|October 15, 1997
Assignment of the human equilibrative nucleoside transporter (hENT1) to 6p21.1-p21.2I R Coe, M Griffiths, J D Young, et al.
Pageof 31